$577M Award For Asahi In Drug Licensing Row Trimmed
A California state judge has cut $70 million from Asahi Kasei Pharma Corp.'s $577 million win in a suit claiming Actelion Ltd. bought CoTherix Inc. in order to undermine a drug...To view the full article, register now.
Already a subscriber? Click here to view full article